Biopharmaceutical company Soleno Therapeutics recently announced a major personnel appointment
Show original
According to documents submitted to the U.S. Securities and Exchange Commission (SEC) on February 25, the company has officially appointed Jennifer Fulk as Chief Financial Officer (CFO), with the appointment to take effect on March 2, 2026. This executive change marks an important step in Soleno Therapeutics' strategic planning. Jennifer Fulk has extensive experience in financial management and is expected to bring new momentum to the company's development. With the arrival of the new CFO, Soleno Therapeutics is expected to further strengthen its financial operations system, providing strong support for future business expansion.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Trending news
MoreCrescent Biopharma Inc recently disclosed that certain revenues recognized in its 2025 financial report actually originate from a $20 million upfront payment made by Kelun-Biotech under a licensing agreement between the two parties for the core asset Cr-001.
Installed Building Products (IBP) recently released an industry outlook, indicating that residential construction activity is expected to continue facing challenges in the short term.
Crypto prices
More
Bitcoin
BTC
$68,196.27
+3.02%
Ethereum
ETH
$2,068.33
+5.60%
Tether USDt
USDT
$1
-0.02%
XRP
XRP
$1.44
+2.73%
BNB
BNB
$626.58
+2.22%
USDC
USDC
$1
-0.00%
Solana
SOL
$87.72
+4.91%
TRON
TRX
$0.2866
+0.33%
Dogecoin
DOGE
$0.09924
+3.51%
Cardano
ADA
$0.2922
+5.19%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now